Company: BLTE
Filing Date: 2025-03-21
Form Type: S-8
Source: 0001104659-25-026633
Chunk: 1

Company: BELITE BIO, INC
Filing Date: 2025-03-21
Form: S-8
Chunk 1
---
     | Emerging growth company x   |

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.¨

<div align='center'>PART I
INFORMATION REQUIRED IN THE SECTION 10(A) PROSPECTUS</div>

ITEM 1. PLAN INFORMATION*

ITEM 2. REGISTRANT INFORMATION AND EMPLOYEE PLAN ANNUAL INFORMATION*

| * | Information required by Part I to be contained in the Section 10(a) prospectus                                             
 is omitted from this Registration Statement in accordance with Rule 428 under the Securities Act and the Note to Part I of 
 Form S-8. The documents containing information specified in this Part I will be separately provided to the participants in 
 the Plans covered by this Registration Statement, as specified by Rule 428(b)(1) under the Securities Act.                 |

<div align='center'>PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</div>

ITEM 3. INCORPORATION OF DOCUMENTS BY REFERENCE

The following documents previously filed with
the Securities and Exchange Commission (the “Commission”) by the Registrant are incorporated herein by reference.

| (1) | The Registrant’s annual report on Form 20-F for the fiscal year ended December 31, 2024 filed with the Commission on March 17, 2025 (File No. 001-41359) pursuant to Section 13(a) of the Securities 
 Exchange Act of 1934, as amended (the “Exchange Act”); and                                                                                                                                           |

| (2) | The description of the Registrant’s ordinary shares contained                                                             
 in the Registrant’s registration statement on Form 8-A under the Exchange Act filed on April 20, 2022, as modified by any 
 amendment or report filed for the purpose of updating such description (File No. 001-41359).                              |

All documents subsequently filed by the Registrant
pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act, prior to the filing of a post-effective amendment which indicates
that all securities offered have been sold, or which deregisters all securities then remaining unsold, shall be deemed to be incorporated
by reference herein and to be a part hereof from the date of filing of such documents.

Any statement contained in